Skip to main content

Advertisement

Log in

Glomerular cytokine expression in murine lupus nephritis

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

Aberrant expression of T helper cell (Th) cytokines is believed to play a central role in the pathogenesis of systemic lupus erythematosus (SLE). While the glomerulus is one of the major targets of lupus inflammation, little is known about the cytokine expression in glomeruli. The current study aimed to explore the profiles of Th cytokine gene expressions in isolated glomeruli of lupus-prone mice.

Methods

Glomeruli were purified from lupus-prone MRL/lpr mice using the magnetic microbead method. Expressions of cytokine genes representing the Th subset and FoxP3 were examined using real-time polymerase chain reaction. Serum levels of these cytokines were also measured by enzyme-linked immunosorbent assay. MRL/n mice were used as controls. Histologic glomerular damages were scored semiquantitatively. To examine the role of TNF-α in glomerular damage, we administered etanercept, a TNF-α antagonist, into the subjects.

Results

Glomerular gene expressions of TNF-α in lpr mice increased with week postpartum and reached statistically significant levels at 16 weeks compared with those of the glomeruli from control mice. Expressions of IFN-γ, IL-4 and FoxP3 also increased, but the difference was not significant. There was a significant increase in serum levels of TNF-α, IFN-γ, and IL-17 and decrease in those of IL-4. Among the genes examined, TNF-α significantly correlated with glomerular damage score. Administration of etanercept did not affect glomerular cytokine expressions or proteinuria and failed to ameliorate histologic glomerular damages.

Conclusion

Our data suggest that Th1 cytokines, especially TNF-α, are dominantly expressed in the glomeruli of lupus-prone mice, but its pathophysiological role remains unclear.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Waldman M, Appel GB. Update on the treatment of lupus nephritis. Kidney Int. 2006;70:1403–12.

    Article  CAS  PubMed  Google Scholar 

  2. Miyake K, Akahoshi M, Nakashima H. Th subset balance in lupus nephritis. J Biomed Biotechnol. 2011;2011:980286.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Uhm WS, Na K, Song GW, et al. Cytokine balance in kidney tissue from lupus nephritis patients. Rheumatology (Oxford). 2003;42:935–8.

    Article  CAS  Google Scholar 

  4. Crispin JC, Oukka M, Bayliss G, et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol. 2008;181(12):8761–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Pisitkun P, Ha HL, Wang H, et al. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity. 2012;37:1104–15.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Xing Q, Su H, Cui J, Wang B. Role of treg cells and TGF-beta1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis. Immunol Invest. 2012;41:15–27.

    Article  CAS  PubMed  Google Scholar 

  7. Takemoto M, Asker N, Gerhardt H, et al. A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol. 2002;161:799–805.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Kikawada E, Lenda DM, Kelley VR. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology. J Immunol. 2003;170:3915–25.

    Article  CAS  PubMed  Google Scholar 

  9. Elshal MF, McCoy JP. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods. 2006;38:317–23.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Liu R, Bal HS, Desta T, Behl Y, Graves DT. Tumor necrosis factor-α mediates diabetes-enhanced apoptosis of matrix-producing cells and impairs diabetic healing. Am J Pathol. 2006;168:757–64.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Masutani K, Akahoshi M, Tsuruya K, et al. Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum. 2001;44:2097–106.

    Article  CAS  PubMed  Google Scholar 

  12. Wang Y, Ito S, Chino Y, et al. Use of laser microdissection in the analysis of renal-infiltrating T cells in MRL/lpr mice. Mod Rheumatol. 2008;18:385–93.

    Article  CAS  PubMed  Google Scholar 

  13. Wang Y, Ito S, Chino Y, et al. Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis. Clin Exp Immunol. 2010;159:1–10.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Schmidt T, Paust HJ, Krebs CF, et al. Function of the T 17/IL-17A immune response in murine lupus nephritis. Arthritis Rheumatol. 2015;67:475–87.

    Article  CAS  PubMed  Google Scholar 

  15. Hondowicz BD, Fields ML, Nish SA, et al. Autoantibody production in lpr/lpr gld/gld mice reflects accumulation of CD4 + effector cells that are resistant to regulatory T cell activity. J Autoimmun. 2008;31:98–109.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Bonelli M, Goschl L, Bluml S, et al. CD4(+)CD25(−)Foxp3(+) T cells: a marker for lupus nephritis? Arthritis Res Ther. 2014;16:R104.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Yazici MU, Orhan D, Kale G, et al. Studying IFN-gamma, IL-17 and FOXP3 in pediatric lupus nephritis. Pediatr Nephrol. 2014;29:853–62.

    Article  PubMed  Google Scholar 

  18. Zhu LJ, Yang X, Yu XQ. Anti-TNF-alpha therapies in systemic lupus erythematosus. J Biomed Biotechnol. 2010;2010:465898.

    PubMed Central  PubMed  Google Scholar 

  19. Williams VL, Cohen PR. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Int J Dermatol. 2011;50:619–25.

    Article  PubMed  Google Scholar 

  20. Almoallim H, Al-Ghamdi Y, Almaghrabi H, Alyasi O. Anti-tumor necrosis factor-alpha induced systemic lupus erythematosus. Open Rheumatol J. 2012;6:315–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Yahya TM, Dhanyamraju S, Harrington TM, et al. Spontaneous resolution of lupus nephritis following withdrawal of etanercept. Ann Clin Lab Sci. 2013;43:447–9.

    PubMed  Google Scholar 

  22. Kelley VR, Wuthrich RP. Cytokines in the pathogenesis of systemic lupus erythematosus. Semin Nephrol. 1999;19:57–66.

    CAS  PubMed  Google Scholar 

  23. Yokoyama H, Kreft B, Kelley VR. Biphasic increase in circulating and renal TNF-alpha in MRL-lpr mice with differing regulatory mechanisms. Kidney Int. 1995;47:122–30.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Ms Rumiko Koitabashi for her excellent technical assistance.

Conflict of interest

The authors have declared that no conflict of interest exists.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hidekazu Ikeuchi.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tshilela, K.A., Ikeuchi, H., Matsumoto, T. et al. Glomerular cytokine expression in murine lupus nephritis. Clin Exp Nephrol 20, 23–29 (2016). https://doi.org/10.1007/s10157-015-1123-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-015-1123-1

Keywords

Navigation